Home/Database/ATSP-7041
ExperimentalPre-clinical

ATSP-7041

ATSP-7041 stapled alpha-helical peptide inhibitor of the p53–MDM2/MDMX interaction

N/A Amino Acids · MW: N/A

Amino Acids

N/A

Molecular Weight

N/A

Half-life

Improved relative to linear peptide; exact value varies

Research Score

4.5

Studies

28

Storage

Store lyophilized at -20°C, reconstituted at 2-8°C

What is ATSP-7041?

A stapled alpha-helical p53-mimetic peptide designed to bind both MDM2 and MDMX. It is a key predecessor scaffold that helped validate dual p53-pathway inhibition by stapled peptides.

Key Benefits & Mechanisms

p53 reactivation

dual MDM2/MDMX inhibition

improved helicity

enhanced cell uptake

Research Summary

ATSP-7041 is widely cited as a proof-of-concept stapled peptide for intracellular protein-protein interaction inhibition. It helped establish that stapling can substantially improve potency and stability versus the corresponding linear peptide.